After years of hesitancy and hand-wringing about A.I., schools are starting to experiment with chatbots — some with enhanced ...

Hopes rise for a new treatment option for people living with lupus, after UCB and Biogen reveal phase 3 data with their anti-CD40L antibody DZP.